+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 3wuw | ||||||
---|---|---|---|---|---|---|---|
タイトル | KIR3DL1 in complex with HLA-B*57:01.I80T | ||||||
要素 |
| ||||||
キーワード | PROTEIN BINDING / Immune receptor complex | ||||||
機能・相同性 | 機能・相同性情報 HLA-B specific inhibitory MHC class I receptor activity / immune response-regulating signaling pathway / IgD immunoglobulin complex / IgA immunoglobulin complex / IgM immunoglobulin complex / IgE immunoglobulin complex / regulation of interleukin-12 production / regulation of dendritic cell differentiation / CD22 mediated BCR regulation / regulation of T cell anergy ...HLA-B specific inhibitory MHC class I receptor activity / immune response-regulating signaling pathway / IgD immunoglobulin complex / IgA immunoglobulin complex / IgM immunoglobulin complex / IgE immunoglobulin complex / regulation of interleukin-12 production / regulation of dendritic cell differentiation / CD22 mediated BCR regulation / regulation of T cell anergy / IgG immunoglobulin complex / regulation of interleukin-6 production / Fc epsilon receptor (FCERI) signaling / natural killer cell mediated cytotoxicity / Classical antibody-mediated complement activation / Initial triggering of complement / TAP binding / FCGR activation / protection from natural killer cell mediated cytotoxicity / immunoglobulin mediated immune response / Role of LAT2/NTAL/LAB on calcium mobilization / Role of phospholipids in phagocytosis / Scavenging of heme from plasma / detection of bacterium / antigen binding / FCERI mediated Ca+2 mobilization / FCGR3A-mediated IL10 synthesis / positive regulation of ferrous iron binding / positive regulation of transferrin receptor binding / secretory granule membrane / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / positive regulation of receptor binding / early endosome lumen / Nef mediated downregulation of MHC class I complex cell surface expression / negative regulation of receptor binding / DAP12 interactions / antigen processing and presentation of endogenous peptide antigen via MHC class Ib / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent / Regulation of Complement cascade / cellular response to iron ion / Endosomal/Vacuolar pathway / Cell surface interactions at the vascular wall / Antigen Presentation: Folding, assembly and peptide loading of class I MHC / FCGR3A-mediated phagocytosis / lumenal side of endoplasmic reticulum membrane / FCERI mediated MAPK activation / B cell receptor signaling pathway / cellular response to iron(III) ion / antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent / negative regulation of forebrain neuron differentiation / regulation of erythrocyte differentiation / peptide antigen assembly with MHC class I protein complex / ER to Golgi transport vesicle membrane / regulation of iron ion transport / response to molecule of bacterial origin / MHC class I peptide loading complex / HFE-transferrin receptor complex / T cell mediated cytotoxicity / positive regulation of T cell cytokine production / antigen processing and presentation of endogenous peptide antigen via MHC class I / MHC class I protein complex / Regulation of actin dynamics for phagocytic cup formation / defense response / negative regulation of neurogenesis / positive regulation of receptor-mediated endocytosis / peptide antigen assembly with MHC class II protein complex / FCERI mediated NF-kB activation / multicellular organismal-level iron ion homeostasis / MHC class II protein complex / cellular response to nicotine / specific granule lumen / positive regulation of cellular senescence / positive regulation of T cell mediated cytotoxicity / recycling endosome membrane / phagocytic vesicle membrane / peptide antigen binding / antigen processing and presentation of exogenous peptide antigen via MHC class II / negative regulation of epithelial cell proliferation / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / positive regulation of immune response / Interferon gamma signaling / Modulation by Mtb of host immune system / positive regulation of T cell activation / Interferon alpha/beta signaling / sensory perception of smell / negative regulation of neuron projection development / positive regulation of protein binding / tertiary granule lumen / DAP12 signaling / MHC class II protein complex binding / late endosome membrane / protein-folding chaperone binding / iron ion transport / ER-Phagosome pathway / T cell differentiation in thymus / early endosome membrane / protein refolding / protein homotetramerization / intracellular iron ion homeostasis / blood microparticle 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) HOMO SAPIENS (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2 Å | ||||||
データ登録者 | Vivian, J.P. / Rossjohn, J. | ||||||
引用 | ジャーナル: J.Immunol. / 年: 2014 タイトル: Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity 著者: O'connor, G.M. / Vivian, J.P. / Widjaja, J.M. / Bridgeman, J.S. / Gostick, E. / Lafont, B.A.P. / Anderson, S.K. / Price, D.A. / Brooks, A.G. / Rossjohn, J. / Mcvicar, D.W. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 3wuw.cif.gz | 162.3 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb3wuw.ent.gz | 124.5 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 3wuw.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 3wuw_validation.pdf.gz | 474.1 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 3wuw_full_validation.pdf.gz | 483 KB | 表示 | |
XML形式データ | 3wuw_validation.xml.gz | 31.1 KB | 表示 | |
CIF形式データ | 3wuw_validation.cif.gz | 45.8 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/wu/3wuw ftp://data.pdbj.org/pub/pdb/validation_reports/wu/3wuw | HTTPS FTP |
-関連構造データ
関連構造データ | 3vh8S S: 精密化の開始モデル |
---|---|
類似構造データ |
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
-タンパク質 , 3種, 3分子 ABG
#1: タンパク質 | 分子量: 31627.004 Da / 分子数: 1 断片: HLA-B*57:01 extracellular domain, UNP residues 25-299 変異: I80T / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: HLA-B, HLA-B*57:01, HLAB / プラスミド: pET-30 / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P18465, UniProt: P01889*PLUS |
---|---|
#2: タンパク質 | 分子量: 11635.002 Da / 分子数: 1 / 断片: Beta 2 Microglobulin, UNP residues 22-119 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: B2M, Beta 2 Microglobulin, CDABP0092, HDCMA22P / プラスミド: pET-30 / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P61769 |
#4: タンパク質 | 分子量: 33513.816 Da / 分子数: 1 断片: KIR3DL1*001 extracellular domains, UNP residues 28-313 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: CD158E, KIR3DL1, KIR3DL1*001, NKAT3, NKB1 / プラスミド: pHLSec / 細胞株 (発現宿主): HEK293 / 発現宿主: HOMO SAPIENS (ヒト) / 参照: UniProt: P43629 |
-タンパク質・ペプチド / 糖 / 非ポリマー , 3種, 497分子 C
#3: タンパク質・ペプチド | 分子量: 966.109 Da / 分子数: 1 / 由来タイプ: 合成 / 詳細: synthesised peptide / 由来: (合成) HOMO SAPIENS (ヒト) / 参照: UniProt: P01834*PLUS | ||
---|---|---|---|
#5: 糖 | #6: 水 | ChemComp-HOH / | |
-詳細
Has protein modification | Y |
---|---|
配列の詳細 | THE SEQUENCE OF THE ENTITY3 OF THIS PROTEIN WAS NOT AVAILABLE AT THE UNIPROT KNOWLEDGEBASE DATABASE ...THE SEQUENCE OF THE ENTITY3 OF THIS PROTEIN WAS NOT AVAILABLE AT THE UNIPROT KNOWLEDGEB |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.53 Å3/Da / 溶媒含有率: 51.45 % |
---|---|
結晶化 | 温度: 293 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5.6 詳細: 16% PEG3350, 2% tacsimate(pH 5.0), 0.1M tri-sodium citrate pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: Australian Synchrotron / ビームライン: MX2 / 波長: 0.9546 Å |
検出器 | タイプ: ADSC QUANTUM 315 / 検出器: CCD / 日付: 2012年8月12日 |
放射 | モノクロメーター: synchrotron / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.9546 Å / 相対比: 1 |
反射 | 解像度: 2→46.472 Å / Num. obs: 49831 / % possible obs: 98.2 % / Observed criterion σ(F): 1 / Observed criterion σ(I): 1 / 冗長度: 3.9 % / Rmerge(I) obs: 0.12 / Net I/σ(I): 8.4 |
反射 シェル | 解像度: 2→2.11 Å / 冗長度: 3.9 % / Rmerge(I) obs: 0.66 / Mean I/σ(I) obs: 2.8 / Num. unique all: 7177 / % possible all: 97.2 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: 3VH8 解像度: 2→40 Å / SU ML: 0.19 / 交差検証法: THROUGHOUT / σ(F): 1.96 / 位相誤差: 25.55 / 立体化学のターゲット値: MLHL
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.6 Å / VDWプローブ半径: 0.9 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL / Bsol: 45.656 Å2 / ksol: 0.356 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2→40 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | Refine-ID: X-RAY DIFFRACTION / Total num. of bins used: 18
|